Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy. (Q31861355)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

0 references

Fernando Cabanillas

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

R B Wilder

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S L Tucker

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C S Ha

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M A Rodriguez

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M A Hess

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J D Cox

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

17-22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

CVP—Remission—maintenance in stage I or II non-Hodgkin's lymphomasPreliminary results of a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

EORTC trial non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin s lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reticulum-cell sarcoma. II. Radiation dosage for each type

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrence Rates Following Radiation Therapy of Nodular and Diffuse Malignant Lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin's malignant lymphoma)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Extranodal Non-Hodgkin's Lymphoma in the Head and Neck: Irradiation and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of radiation therapy in localized non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The integration of radiotherapy into the primary treatment of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Histopathologic subclassification of diffuse histiocytic lymphoma and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Localized primary malignant lymphoma of bone.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Extending the elements of tree-structured regression

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined modality therapy in stage III and stage IIIE diffuse large cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cyclophosphamide treatment of acute myelocytic leukemia. Studies in the BNML rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lucy Wortham James Lecture. Subclinical disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical debulking is associated with improved survival in stage I-II diffuse large cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of morphologic subdivision in diffuse large cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901383-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(00)01383-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163493%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31861355&oldid=1602959679"